Biotechnology
I-Mab Announces Leadership Transitions
ROCKVILLE, Md., July 15, 2024 /PRNewswire/ -- I-Mab (NASDAQ: IMAB) (the "Company" or "I-Mab"), a U.S.-based, global biotech company, announced today that the Board of Directors of the Company has appointed Mr.Wei Fu as the Chairman of the Board of Directors. He succeeds Dr.Pamela M. Klein, who st...
2024-07-15 19:30
1723
HanAll Biopharma Appoints Christopher W Slavinsky as Chief Business Development and Legal Officer
ROCKVILLE, Md. and SEOUL, South Korea, July 15, 2024 /PRNewswire/ -- HanAll
Biopharma (KRX: 009420.KS) announced today the appointment ofChristopher W.
Slavinsky as Chief Business Development and Legal Officer.
2024-07-15 19:00
1611
Smart Binhai, Glorious Competition! 2024 China Tianjin Binhai New Area Talent Innovation and Entrepreneurship Competition (Overseas Competition) Hong Kong SAR Division Finals to Begin Soon
HONG KONG, July 15, 2024 /PRNewswire/ -- With the surging waves of global innovations, the 2024 China Tianjin Binhai New Area Talent Innovation and Entrepreneurship Competition (Overseas Competition) Hong Kong SAR Division Finals will soon kick off in Hong Kong SAR on 17th July 2024. As the gatew...
2024-07-15 17:43
1647
CPHI & PMEC Shenzhen 2024: Fostering New Opportunities in Asia and China's Greater Bay Area
SHANGHAI, July 15, 2024 /PRNewswire/ -- CPHI & PMEC China 2024 concluded in June with an exceptional turnout of visitors, setting a new attendance record. Notably, the number of international visitors grew to 11,563, and professionals from the end-to-end pharmaceutical supply chain made meaningfu...
2024-07-15 13:59
1775
Everest Medicines Announces Positive Topline Results from Maintenance Period of Etrasimod Phase 3 Clinical Trial Conducted in Asia for the Treatment of Moderately-to-Severely Active Ulcerative Colitis
SHANGHAI, July 15, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced positive topline data results of the ...
2024-07-15 13:44
1853
Basecare Medical (2170. HK) revenue growth exceeds 50% in 2024H1
SUZHOU, China , July 15, 2024 /PRNewswire/ -- Basecare Medical (2170. HK) released an unaudited interim performance forecast onJuly 12th, stating that the company's revenue for the first half of the year was approximatelyRMB 127 million to RMB 138 million, an increase of approximately 49% to 62% ...
2024-07-15 12:17
3222
Nona Biosciences Enters into Collaboration Agreement with Alaya.bio to Advance CAR-T Cell Therapy
CAMBRIDGE, Mass., July 14, 2024 /PRNewswire/ -- Nona Biosciences, a global biotechnology company providing a total solution from "Idea to IND" (I to ITM), ranging from target validation and antibody discovery through preclinical research, announced today that it has entered into a collaboration a...
2024-07-15 10:12
1216
MGI Tech Launches DNBSEQ-G400RS FluoXpert in the APAC Region at Medlab Asia & Asia Health 2024
BANGKOK, July 12, 2024 /PRNewswire/ -- MGI Tech Co., Ltd. ("MGI"), a company committed to building core tools and technologies that drive innovation in life science, today launched DNBSEQ-G400RS FluoXpert in the APAC region and opened early access to the platform at Medlab Asia & Asia Health 2024...
2024-07-12 16:57
3402
Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases
HONG KONG, GERMANTOWN, Md. and SUZHOU, China, July 12, 2024 /PRNewswire/ -- Sirnaomics Ltd.(the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading biopharmaceutical company engaging in discovery and development of advanced RNAi therapeutics, an...
2024-07-12 16:53
4280
Origin Agritech Chairman and CEO Dr. Gengchen Han Provides Business Updates and Answers Questions from Investors
BEIJING, July 11, 2024 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, provided a business update from Dr. Gengchen Han, Chairman and CEO of Origin Agritech. Dear Shareholders, We are pleased to provide you with...
2024-07-11 21:00
4727
First Patient Dosed in Phase I Clinical Trial of YOLT-201
SHANGHAI, July 11, 2024 /PRNewswire/ -- YolTech Therapeutics, a biotech company developing in vivo gene editing therapies to treat rare genetic diseases, announced today the successful enrollment of the first patient in the Phase I clinical trial of YOLT-201, its independently developed in vivo g...
2024-07-11 20:11
1746
Sanyou Bio and BioGeometry join forces to create a next-generation Antibody Drug Discovery Platform driven by AIGC
SHANGHAI, July 11, 2024 /PRNewswire/ -- Recently, BioGeometry and Sanyou Bio jointly announced the signing of a strategic partnership agreement. BioGeometry is a digital biology pioneer company that specializes in AI-driven protein design and R&D platform. Sanyou Bio is a world-leading high-tech...
2024-07-11 20:00
1843
CUHK identifies novel gut microbiome biomarkers to facilitate diagnosis of autism spectrum disorders
Pilot clinical study shows modulation of gut microbiome alleviates anxiety symptoms HONG KONG, July 11, 2024 /PRNewswire/ -- A research team from The Chinese University of Hong Kong (CUHK)'s Faculty of Medicine (CU Medicine) has conducted a large cohort study among 1,627 children with and witho...
2024-07-11 18:36
7289
Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL)
Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL) TOKYO, July 11, 2024 /PRNewswire/ -- The National Cancer Center (Tokyo, Japan ) and TheUniversity of Pennsylvania (Philadelphia, PA, USA) have licensed patent rights directed to a chimeric...
2024-07-11 14:24
2448
Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL)
Initiation of cell therapy research and development program for adult T-Cell leukemia / lymphoma (ATLL) TOKYO, July 11, 2024 /PRNewswire/ -- The National Cancer Center (Tokyo, Japan ) and TheUniversity of Pennsylvania (Philadelphia, PA, USA) have licensed patent rights directed to a chimeric...
2024-07-11 14:21
2009
ADM Korea Announces Niclosamide-based Metabolic Anticancer Drug's First Clinical Trial Target as 'Prostate Cancer Patients Resistant to Hormone Therapy'
* IND for clinical study for combination therapy with hormone therapy in prostate cancer patients to be submitted in August, 2024. * Niclosamide-based metabolic anticancer drug aims to block signaling pathways that allow cancer cells to evade anticancer effects, potentially solving the issue ...
2024-07-11 14:07
1953
Borsch Med Launches Ikigai Health Campaign with Zeria's Chondro Max
Community Outreach Campaign Champions Healthy Lifestyle for Healthy Joints SINGAPORE, July 11, 2024 /PRNewswire/ -- Borsch Med Pte Ltd (BM), a leading Health and Nutrition company based inSingapore, and operated and managed by professionals in Goh Joo Hin Pte Ltd (GJH), launched the"Enjoy Your Li...
2024-07-11 12:13
2166
Telix Welcomes CMS Proposal to Improve Payment for Specialised Diagnostic Radiopharmaceuticals
MELBOURNE, Australia, July 11, 2024 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today welcomes proposed changes announced by the Centers for Medicare & Medicaid Services (CMS) for the Hospital Outpatient Prospective Payment System (OPPS) rule to improve payments ...
2024-07-11 08:21
1868
Kangsters Unveils Revolutionary Treadmills at Rollettes Experience 2024: Celebrating Innovation and Empowerment
LOS ANGELES, July 10, 2024 /PRNewswire/ -- Kangsters, the pioneering South Korean adaptive tech startup, proudly announces its participation in the Rollettes Experience 2024. This renowned event, now celebrating its 11th anniversary, will be held fromJuly 11-14 at the Sheraton Hotel in Los Angele...
2024-07-11 00:00
2144
Eligo Publishes in Nature a Landmark Study That Unlocks Genome Editing of Bacteria in the Gut
PARIS, July 10, 2024 /PRNewswire/ -- For the first time, a team of scientists at Eligo has demonstrated it was possible to genetically modify bacteria with nearly 100% efficiency directly in the gut of animals. This work provides scientists with a novel strategy to better understand how genes fro...
2024-07-10 23:00
1729
Week's Top Stories
Most Reposted
Rocket Travel by Agoda Shares Revealing New Report and Showcases Solution to Transform Hotel Distribution
[Picked up by 313 media titles]
2024-11-21 10:30Rockwell Automation and Microsoft Deliver on a Shared Vision to Accelerate Industrial Transformation
[Picked up by 308 media titles]
2024-11-20 13:29Durabook and Parent Company, Twinhead International Corp., Celebrate 40 Years of Innovation in Computing Solutions
[Picked up by 301 media titles]
2024-11-20 16:30
Travel loyalty programs to focus on offering personalized and flexible customer experiences in 2025
[Picked up by 298 media titles]
2024-11-19 10:42Philips and Edith Cowan University Australia Collaborate to Equip the Next Generation of Healthcare Professionals to leverage new technologies
[Picked up by 284 media titles]
2024-11-20 09:00
Most Read
Strategic Forum in Chongqing Drives Expansion of New Western Land-Sea Corridor
2024-11-16 14:15
5203
